Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367469 · ClinicalTrials.gov registry record
Tryptophan Metabolism in Human Brain Tumors
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 105
- Enrollment target
NCT02367469 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 105 participants.
The verdict
NCT02367469 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine the potential clinical utility of PET imaging using the radiotracer \[C-11\]alpha-methyl-L-tryptophan in the diagnosis, differentiation and monitoring of various brain tumors, both before and after initial treatment. We will also study mechanisms and clinical significance of abnormal brain tumor tryptophan metabolism using resected tumor tissues.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2014-02 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367469
The ClinicalTrials.gov registry entry for NCT02367469 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02367469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02367469 about?
NCT02367469 is a clinical study titled "Tryptophan Metabolism in Human Brain Tumors". The main purpose of this study is to determine the potential clinical utility of PET imaging using the radiotracer \[C-11\]alpha-methyl-L-tryptophan in the diagnosis, differentiation and monitoring of various brain tumors, both before and after initial treatment. We will also study mechanisms and cl...
What is the current status of trial NCT02367469?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2014-02. Estimated completion is 2021-12-31.
Who is sponsoring clinical trial NCT02367469?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.